MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
American Heart Journal
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,105 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,105 works in the cohort · of 4,299,418page 9 of 23

Labels cover 0 of 1,105 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,105 of 1,105 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Preventing tomorrow's sudden cardiac death today
Sana M. Al‐Khatib, Gillian D Sanders, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark D. Carlson +19 more
2007· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
47
citations
affunlabeled
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration
Alex Pitcher, Jonathan Emberson, Ronald V. Lacro, Lynn A. Sleeper, Mario Stylianou, Lynn Mahony +28 more
2015· article· en· American Heart Journal· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearchconsensus · metaresearch
47
citations
affno abstractunlabeled
Baseline differences in the HF-ACTION trial by sex
Ileana L. Piña, Peter Kokkinos, Andrew Kao, Vera Bittner, Matt Saval, Bob Clare +10 more
2009· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
47
citations
affno abstractunlabeled
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
Christian Zanchin, Konstantinos C. Koskinas, Yasushi Ueki, Sylvain Losdat, Jonas Häner, Sarah Bär +18 more
2021· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
44
citations
affno abstractunlabeled
Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials
Camille Frazier, Svati H. Shah, Paul W. Armstrong, Manjushri Bhapkar, Darren K. McGuire, Zygmunt Sadowski +5 more
2005· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
44
citations
afffundno abstractunlabeled
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Catherine Martel, Christopher B. Granger, M Ghiţescu, Amanda Stebbins, Annik Fortier, Paul W. Armstrong +2 more
2012· article· en· American Heart Journal· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
42
citations

How this was built: Screen · Findings · About